Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Backed by Science: Here’s How We Can Eliminate COVID-19 23/01/2022 Guy Marks, Brendan Crabb & Raina MacIntyre As the WHO Executive Board resumes talks this week on a much-discussed Pandemic Accord, and other preparedness measures, three noted infectious disease experts chart a course for “eliminating” SARS-COV2 – warning that will take more sustained global coordination and determination than what has been seen so far. At the outbreak of World War 1 in […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> WHO’s Emergencies Expert Group Re-Asserts Stance Against COVID ‘Vaccine Passports’ for International Travel 20/01/2022 Elaine Ruth Fletcher A World Health Organization Emergencies Expert Committee has once again re-asserted a recommendation to abolish vaccine requirements for international travel – going well against the grain of current trends – particularly in light of the brouhaha seen over Sunday’s deportation of Serbian tennis star Novak Djokovic from Australia. The WHO expert group, made of some […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Report on Pandemic Response is Slashed Ahead of WHO Executive Board Meeting 19/01/2022 Kerry Cullinan One of the more complicated tasks facing next week’s World Health Organization (WHO) Executive Board (EB) is how to take forward negotiations on an ‘instrument’ to address future pandemics – and even the report to the board about this has been slashed. The past two years of vaccine hoarding, nationalism and fights about the origins […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Backed by Science: Here’s How We Can Eliminate COVID-19 23/01/2022 Guy Marks, Brendan Crabb & Raina MacIntyre As the WHO Executive Board resumes talks this week on a much-discussed Pandemic Accord, and other preparedness measures, three noted infectious disease experts chart a course for “eliminating” SARS-COV2 – warning that will take more sustained global coordination and determination than what has been seen so far. At the outbreak of World War 1 in […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> WHO’s Emergencies Expert Group Re-Asserts Stance Against COVID ‘Vaccine Passports’ for International Travel 20/01/2022 Elaine Ruth Fletcher A World Health Organization Emergencies Expert Committee has once again re-asserted a recommendation to abolish vaccine requirements for international travel – going well against the grain of current trends – particularly in light of the brouhaha seen over Sunday’s deportation of Serbian tennis star Novak Djokovic from Australia. The WHO expert group, made of some […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Report on Pandemic Response is Slashed Ahead of WHO Executive Board Meeting 19/01/2022 Kerry Cullinan One of the more complicated tasks facing next week’s World Health Organization (WHO) Executive Board (EB) is how to take forward negotiations on an ‘instrument’ to address future pandemics – and even the report to the board about this has been slashed. The past two years of vaccine hoarding, nationalism and fights about the origins […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Backed by Science: Here’s How We Can Eliminate COVID-19 23/01/2022 Guy Marks, Brendan Crabb & Raina MacIntyre As the WHO Executive Board resumes talks this week on a much-discussed Pandemic Accord, and other preparedness measures, three noted infectious disease experts chart a course for “eliminating” SARS-COV2 – warning that will take more sustained global coordination and determination than what has been seen so far. At the outbreak of World War 1 in […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> WHO’s Emergencies Expert Group Re-Asserts Stance Against COVID ‘Vaccine Passports’ for International Travel 20/01/2022 Elaine Ruth Fletcher A World Health Organization Emergencies Expert Committee has once again re-asserted a recommendation to abolish vaccine requirements for international travel – going well against the grain of current trends – particularly in light of the brouhaha seen over Sunday’s deportation of Serbian tennis star Novak Djokovic from Australia. The WHO expert group, made of some […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Report on Pandemic Response is Slashed Ahead of WHO Executive Board Meeting 19/01/2022 Kerry Cullinan One of the more complicated tasks facing next week’s World Health Organization (WHO) Executive Board (EB) is how to take forward negotiations on an ‘instrument’ to address future pandemics – and even the report to the board about this has been slashed. The past two years of vaccine hoarding, nationalism and fights about the origins […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> WHO’s Emergencies Expert Group Re-Asserts Stance Against COVID ‘Vaccine Passports’ for International Travel 20/01/2022 Elaine Ruth Fletcher A World Health Organization Emergencies Expert Committee has once again re-asserted a recommendation to abolish vaccine requirements for international travel – going well against the grain of current trends – particularly in light of the brouhaha seen over Sunday’s deportation of Serbian tennis star Novak Djokovic from Australia. The WHO expert group, made of some […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Report on Pandemic Response is Slashed Ahead of WHO Executive Board Meeting 19/01/2022 Kerry Cullinan One of the more complicated tasks facing next week’s World Health Organization (WHO) Executive Board (EB) is how to take forward negotiations on an ‘instrument’ to address future pandemics – and even the report to the board about this has been slashed. The past two years of vaccine hoarding, nationalism and fights about the origins […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> WHO’s Emergencies Expert Group Re-Asserts Stance Against COVID ‘Vaccine Passports’ for International Travel 20/01/2022 Elaine Ruth Fletcher A World Health Organization Emergencies Expert Committee has once again re-asserted a recommendation to abolish vaccine requirements for international travel – going well against the grain of current trends – particularly in light of the brouhaha seen over Sunday’s deportation of Serbian tennis star Novak Djokovic from Australia. The WHO expert group, made of some […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Report on Pandemic Response is Slashed Ahead of WHO Executive Board Meeting 19/01/2022 Kerry Cullinan One of the more complicated tasks facing next week’s World Health Organization (WHO) Executive Board (EB) is how to take forward negotiations on an ‘instrument’ to address future pandemics – and even the report to the board about this has been slashed. The past two years of vaccine hoarding, nationalism and fights about the origins […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> WHO’s Emergencies Expert Group Re-Asserts Stance Against COVID ‘Vaccine Passports’ for International Travel 20/01/2022 Elaine Ruth Fletcher A World Health Organization Emergencies Expert Committee has once again re-asserted a recommendation to abolish vaccine requirements for international travel – going well against the grain of current trends – particularly in light of the brouhaha seen over Sunday’s deportation of Serbian tennis star Novak Djokovic from Australia. The WHO expert group, made of some […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Report on Pandemic Response is Slashed Ahead of WHO Executive Board Meeting 19/01/2022 Kerry Cullinan One of the more complicated tasks facing next week’s World Health Organization (WHO) Executive Board (EB) is how to take forward negotiations on an ‘instrument’ to address future pandemics – and even the report to the board about this has been slashed. The past two years of vaccine hoarding, nationalism and fights about the origins […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> WHO’s Emergencies Expert Group Re-Asserts Stance Against COVID ‘Vaccine Passports’ for International Travel 20/01/2022 Elaine Ruth Fletcher A World Health Organization Emergencies Expert Committee has once again re-asserted a recommendation to abolish vaccine requirements for international travel – going well against the grain of current trends – particularly in light of the brouhaha seen over Sunday’s deportation of Serbian tennis star Novak Djokovic from Australia. The WHO expert group, made of some […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Report on Pandemic Response is Slashed Ahead of WHO Executive Board Meeting 19/01/2022 Kerry Cullinan One of the more complicated tasks facing next week’s World Health Organization (WHO) Executive Board (EB) is how to take forward negotiations on an ‘instrument’ to address future pandemics – and even the report to the board about this has been slashed. The past two years of vaccine hoarding, nationalism and fights about the origins […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO’s Emergencies Expert Group Re-Asserts Stance Against COVID ‘Vaccine Passports’ for International Travel 20/01/2022 Elaine Ruth Fletcher A World Health Organization Emergencies Expert Committee has once again re-asserted a recommendation to abolish vaccine requirements for international travel – going well against the grain of current trends – particularly in light of the brouhaha seen over Sunday’s deportation of Serbian tennis star Novak Djokovic from Australia. The WHO expert group, made of some […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Report on Pandemic Response is Slashed Ahead of WHO Executive Board Meeting 19/01/2022 Kerry Cullinan One of the more complicated tasks facing next week’s World Health Organization (WHO) Executive Board (EB) is how to take forward negotiations on an ‘instrument’ to address future pandemics – and even the report to the board about this has been slashed. The past two years of vaccine hoarding, nationalism and fights about the origins […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Report on Pandemic Response is Slashed Ahead of WHO Executive Board Meeting 19/01/2022 Kerry Cullinan One of the more complicated tasks facing next week’s World Health Organization (WHO) Executive Board (EB) is how to take forward negotiations on an ‘instrument’ to address future pandemics – and even the report to the board about this has been slashed. The past two years of vaccine hoarding, nationalism and fights about the origins […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Report on Pandemic Response is Slashed Ahead of WHO Executive Board Meeting 19/01/2022 Kerry Cullinan One of the more complicated tasks facing next week’s World Health Organization (WHO) Executive Board (EB) is how to take forward negotiations on an ‘instrument’ to address future pandemics – and even the report to the board about this has been slashed. The past two years of vaccine hoarding, nationalism and fights about the origins […] Continue reading -> Posts navigation Older postsNewer posts